CD Bioparticle launches Normal Organoids Kits(Human-Derived) for basic research, drug screening, toxicology evaluation, and regenerative medicine. NEW YORK, NY, UNITED STATES, May 27, 2026 / EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its Normal Organoids Kits (Human-Derived).